Clinical Trials and Translational Research Advisory Committee
Presentations from the Meeting Held November 2, 2016
(Presentation File Format - PDF --> Get Adobe Reader)
November 2
| NIH VIDEOCAST |
| NCI ACTING DIRECTOR'S UPDATE | |
|
NCI Acting Director's Update |
Dr. Lowy Dr. Doroshow |
| BLUE RIBBON PANEL RECOMMENDATIONS AND DISCUSSION | |
|
Blue Ribbon Panel Recommendations Select Blue Ribbon Panel Recommendations � For CTAC Discussion |
Dr. Singer Dr. Doroshow |
| PRECISION MEDICINE CLINICAL TRIALS: LESSON LEARNED | |
|
Precision Medicine Clinical Trials: A Learning Process |
Dr. Abrams |
| NEW PRECISION MEDICINE INITIATIVES | |
|
New Precision Medicine Initiatives Update on Cancer Center, SPORE, and P01 Supplements and New Initiatives for Precision Medicine |
Dr. Abrams Dr. Hecht |
| TRIAL REPORTING IN CLINICALTRIALS.GOV - THE FINAL RULE | |
|
Update on Trial Reporting Requirements NIH Policy on Dissemination of NIH-Funded Clinical Trial Information Trial Reporting in ClinicalTrials.gov - The Final Rule Toward a New Era of Trust and Transparency in Clinical Trials |
Dr. Zarin |
| BIOMARKERS IN CLINICAL TRIALS: THE BIOMARKERS, IMAGING AND QUALITY OF LIFE STUDIES FUNDING PROGRAM (BIQSFP) | |
|
Biomarkers in Clinical Trials: The Biomarkers, Imaging and Quality of Life Studies Funding Program (BIQSFP) List of Active BIQSFP Trials |
Dr. Doroshow |
| DEVELOPMENT AND IMPLEMENTATION OF THE CANCER PATIENT TOBACCO USE QUESTIONNAIRE | |
|
Development and Implementation of the Cancer Patient Tobacco Use Questionnaire Effects of Smoking on Treatment, Efficacy, and Clinical Outcomes in the S1602 Phase III Non-Muscle Invasive Bladder Cancer (NMIBC) study C-TUQ Flyer Cancer Patient Tobacco Use Questionnaire (C-TUQ) Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research |
Dr. Land Dr. LeBlanc |
| ONGOING AND NEW BUSINESS | |
|
Ongoing and New Business |
Dr. Davidson |
| INFORMATIONAL ITEMS | |
|
Legislative Update |